There are no products in your shopping cart.
Description: NEUROMINS - S-GEL is an excellent source of docosahexaenoic acid (DHA), an omega-3 fatty acid, in its natural, triglyceride form. Neuromins DHA is obtained from marine microalgae, and is currently the only vegetarian source of DHA. This single nutrient fatty acid supplement is free of eicosapentaenoic acid (EPA), an omega-3 fatty acid which is present in fish oil supplements along with DHA. Neuromins is a highly purified DHA-only oil completely free of cholesterol. Size: 60 | Price: $28.40 |
| Symptoms: | |
| Brand: | |
| Nutritional Supplements: |
Typical diets in developed countries deliver large amounts of saturated fatty acids and the polyunsaturated omega-6 linoleic and arachidonic acids and low levels of omega-3 fatty acids. Throughout evolution, humans were accustomed to diets providing roughly equal amounts of omega-6 and omega-3 fatty acids. However, during the last 200 years, the ratio of dietary omega-6:omega-3 fatty acids increased from about 1:1 to 20-25:1. Leading health professionals now recommend ratios between 4:1 and 10:1. The omega-3 fatty acid EPA is the direct precursor for the anti-inflammatory prostaglandins E 1 and E 3 , whereas DHA is of primary importance for the structural integrity of neuronal membranes. DHA is essential for brain and visual development and is vital throughout pregnancy to support fetal brain growth and formation of the retina and visual cortex. As the most abundant fatty acid in the brain, adequate amounts of DHA are needed throughout infancy and adulthood for ongoing optimal function. DHA is the most predominant fatty acid in breast milk, and thus contributes to continued brain and eye development of newborns. Pregnancy and lactation can deplete a woman's stores of DHA and dietary or supplemental sources are needed to rebuild the levels. DHA helps ensure optimal composition of nerve cell membranes necessary for effective transmission of electrical signals between the brain, retina, and other parts of the nervous system. Low levels of DHA may adversely influence behavior and mental performance, and have been correlated with changes in disposition, memory loss, and visual and other neurological conditions.
Neuromins may be a useful dietary supplement for adults and children who do not consume enough oily fish, and other sources of omega-3 fatty acids in their diets to receive desirable amounts of DHA.
Each softgel contains:
Neuromins DHA Oil (derived from microalgae)......................500 mg Supplying: Docosahexaenoic Acid (DHA, 22:6)......100 mg
One to two softgels daily as a dietary supplement, or as directed by a physician. Take with food.
No adverse effects have been reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
Birch EE, Birch DG, Hoffman DR, et al. Visual maturation of term infants fed omega 3 long chain polyunsaturated fatty acid (LCPUFA) supplemented formula. ARVO Meeting 1996; New York. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992; 340: 810-813. Florey C Du V, Leech AM, Blackhall A. Infant feeding and mental and motor development at 18 months of age in first born singletons. Internatl J Epidemiol 1995;24:S21-26. Hack M, Breslau N, Aram D, Weissman B, et al. The effect of very low birth weight and social risk on neurocognitive abilities at school age. J Dev Behav Pediatr 1992;13:412-420. (continued on reverse) Product Data Douglas Laboratories ® Lucas A, Morley R, Cole TL, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born premature. Lancet 1992;339:261-264. Markides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994;60:189-194. Makrides M, Neumann MA, Gibson RA. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Europ J Clin Nutr 1996;50:352-357. Martinez MJ. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992; 120:S129-138. Morrow-Tlucak M, et al. Breastfeeding and cognitive development in the first 2 yes of life. Soc Sci Med 1988;26:635-639. Neuringer M, Anderson GJ, Conner WE. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Ann Rev Nutr. 1988;8:517-541. Saigal S, Rosenbaum P, Szatmari P, Campbell D. Learning disabilities and school problems in a regional cohort of extremely low birthweight children: a comparison with term controls. J Dev Behav Pediatr 1991;12:292-300. Salem N, Kim HY, Yergey JA. Docosahexaenoic acid: membrane function and metabolism. Health Effects of Polyunsaturated Fatty acids in Seafoods. A Simopoulos, RP Kifer and RE martin, Eds, 1986;263-318. Smedler AC, Faxelius G, Bremme K, Lagerstrom M. Psychological development in children born with very low birthweight after severe intrauterine growth retardation: a ten year follow-up study. Acta Paediatr 1992;81:197-203. Stevens IJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995;62:761-768. Stordy BJ. Dark adaptation, docosahexaenoic acid and dyslexia. International Conference on Highly Unsaturated Fatty Acids in Nutrition and Disease Prevention 1996; Barcelona, Spain. US Dept Agriculture food records, USDA, Economic Research Service. Food Consumption, Prices, and Expenditures Annual and Consumer Expend. Patterns, Series G881-915.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Manufactured by Douglas Laboratories 600 Boyce Road Pittsburgh, PA 15205 800-245-4440
![]() |
|||















